U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Both therapeutic regimens (amlodipine besylate and candesartan cilexetil) were very effective in lowering office BP after 12 weeks of treatment. There was a trend towards better self-measured BP ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.
Samsung is working on a new rugged tablet, the Galaxy Tab Active 5 Pro, powered by the Snapdragon 7s Gen 3. The company is also working on the Galaxy Tab S10 FE and Tab S10 FE Plus, powered by the ...
I am an 84-year-old male in fairly good health for my age. I take 8-10 pills a day, including two over-the-counter medications. I take four or five in ...
The recommended trazodone dosage for major depressive disorder (MDD) is between 150 milligrams (mg) and 400 mg. Trazodone is an oral tablet that you typically take in divided doses. It is ...
Mounjaro (tirzepatide) is a prescription drug that’s used to treat type 2 diabetes. The drug comes as a liquid solution that you inject under your skin, typically once per week. Mounjaro ...
JSW MG Motor India has unveiled two new cars at the Bharat Mobility Global Expo 2025. Introducing the MG Cyberster, India’s first all-electric roadster, and the MG M9, the country’s first ...
addition of hydrochlorothiazide 12.5 mg/d; up-titration of hydrochlorothiazide to 25 mg/d; addition of amlodipine besylate 5 mg/d; and up-titration of amlodipine besylate to 10 mg/d. Patients who ...
The best tablets of 2024 were the new iPad Pro M4 family, Apple's sleek and thin new iPad Pro models. Will 2025 be the year that Android tablets close the gap on Apple's premium tabs? We don't ...